Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Expanded Access Protocol for Providing Tabelecleucel to Patients With Epstein-Barr Virus-Associated Viremia or Malignancies for Whom There Are No Appropriate Alternative Therapies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02822495
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:06.752802+00:00
Published At
2023-06-15T00:00:00+00:00
Record Updated At
2023-06-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Epstein-Barr Virus (EBV) Infections", "Lymphoproliferative Disorders", "EBV+ Associated Lymphoma", "EBV+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)", "Epstein-Barr Viremia", "Lymphoma, AIDS-related", "Epstein-Barr Virus-associated Lymphoproliferative Disease (EBV+ LPD) With Primary Immunodeficiency (PID)", "Leiomyosarcoma (LMS)", "Nasopharyngeal Carcinoma (NPC)", "Epstein-Barr Virus-associated Lymphoproliferative Disease (EBV+ LPD) With Acquired Immunodeficiency (AID)", "Solid Organ Transplant Complications", "Stem Cell Transplant Complications"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-06-15"
protocolSection.identificationModule.nctId
"NCT02822495"
protocolSection.identificationModule.officialTitle
"Expanded Access Protocol for Providing Tabelecleucel to Patients With Epstein-Barr Virus-Associated Viremia or Malignancies for Whom There Are No Appropriate Alternative Therapies"
protocolSection.statusModule.overallStatus
"NO_LONGER_AVAILABLE"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Epstein-Barr Virus (EBV) Infections (protocolSection.conditionsModule.conditions)
  • Lymphoproliferative Disorders (protocolSection.conditionsModule.conditions)
  • EBV+ Associated Lymphoma (protocolSection.conditionsModule.conditions)
  • EBV+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD) (protocolSection.conditionsModule.conditions)
  • Epstein-Barr Viremia (protocolSection.conditionsModule.conditions)
  • Lymphoma, AIDS-related (protocolSection.conditionsModule.conditions)
  • Epstein-Barr Virus-associated Lymphoproliferative Disease (EBV+ LPD) With Primary Immunodeficiency (PID) (protocolSection.conditionsModule.conditions)
  • Leiomyosarcoma (LMS) (protocolSection.conditionsModule.conditions)
  • Nasopharyngeal Carcinoma (NPC) (protocolSection.conditionsModule.conditions)
  • Epstein-Barr Virus-associated Lymphoproliferative Disease (EBV+ LPD) With Acquired Immunodeficiency (AID) (protocolSection.conditionsModule.conditions)
  • Solid Organ Transplant Complications (protocolSection.conditionsModule.conditions)
  • Stem Cell Transplant Complications (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.